The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
APOGEE THERAPEUTICS INC | COM | 03770N101 | 41,224,731 | 701,817 | SH | SOLE | 701,817 | 0 | 0 | |||
ARCELLX INC | COMMON STOCK | 03940C100 | 66,808,000 | 800,000 | SH | Call | SOLE | 800,000 | 0 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | 334,040,000 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | |||
ARGENX SE | SPONSORED ADR | 04016X101 | 260,401,138 | 480,374 | SH | SOLE | 480,374 | 0 | 0 | |||
ARVINAS INC | COM | 04335A105 | 57,633,239 | 2,339,961 | SH | SOLE | 2,339,961 | 0 | 0 | |||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 44,977,435 | 200,336 | SH | SOLE | 200,336 | 0 | 0 | |||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 49,785,430 | 4,609,762 | SH | SOLE | 4,609,762 | 0 | 0 | |||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 7,308,000 | 1,160,000 | SH | SOLE | 1,160,000 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 128,602,655 | 2,516,686 | SH | SOLE | 2,516,686 | 0 | 0 | |||
CULLINAN THERAPEUTICS INC | COM | 230031106 | 38,853,758 | 2,321,013 | SH | SOLE | 2,321,013 | 0 | 0 | |||
DISC MEDICINE INC | COM | 254604101 | 73,597,961 | 1,497,720 | SH | SOLE | 1,497,720 | 0 | 0 | |||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 74,443,001 | 2,789,172 | SH | SOLE | 2,789,172 | 0 | 0 | |||
ERASCA INC | COM | 29479A108 | 29,124,025 | 10,668,141 | SH | SOLE | 10,668,141 | 0 | 0 | |||
IMMATICS N.V | SHS | N44445109 | 44,554,475 | 3,904,862 | SH | SOLE | 3,904,862 | 0 | 0 | |||
IMMUNOVANT INC | COM | 45258J102 | 38,854,198 | 1,362,827 | SH | SOLE | 1,362,827 | 0 | 0 | |||
JANUX THERAPEUTICS INC | COM | 47103J105 | 109,058,077 | 2,400,574 | SH | SOLE | 2,400,574 | 0 | 0 | |||
KEROS THERAPEUTICS INC | COM | 492327101 | 30,488,899 | 525,037 | SH | SOLE | 525,037 | 0 | 0 | |||
KURA ONCOLOGY INC | COM | 50127T109 | 84,634,012 | 4,331,321 | SH | SOLE | 4,331,321 | 0 | 0 | |||
MERUS N V | COM | N5749R100 | 122,647,653 | 2,454,917 | SH | SOLE | 2,454,917 | 0 | 0 | |||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 46,965,222 | 931,480 | SH | SOLE | 931,480 | 0 | 0 | |||
NUVALENT INC | COM | 670703107 | 511,500,000 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | |||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 65,712,984 | 5,503,600 | SH | SOLE | 5,503,600 | 0 | 0 | |||
ORUKA THERAPEUTICS INC | COM | 687604108 | 17,638,867 | 719,660 | SH | SOLE | 719,660 | 0 | 0 | |||
PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | 12,277,888 | 919,692 | SH | SOLE | 919,692 | 0 | 0 | |||
PLIANT THERAPEUTICS INC | COM | 729139105 | 34,801,288 | 3,104,486 | SH | SOLE | 3,104,486 | 0 | 0 | |||
REVOLUTION MEDICINES INC | COM | 76155X100 | 240,993,936 | 5,314,089 | SH | SOLE | 5,314,089 | 0 | 0 | |||
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 37,279,557 | 1,267,581 | SH | SOLE | 1,267,581 | 0 | 0 | |||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 80,266,236 | 2,440,445 | SH | SOLE | 2,440,445 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 31,629,936 | 276,800 | SH | Call | SOLE | 276,800 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 71,730,936 | 627,732 | SH | SOLE | 627,732 | 0 | 0 | |||
VERA THERAPEUTICS INC | CL A | 92337R101 | 48,480,814 | 1,096,851 | SH | SOLE | 1,096,851 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 65,876,925 | 2,895,689 | SH | SOLE | 2,895,689 | 0 | 0 | |||
Y-MABS THERAPEUTICS INC | COM | 984241109 | 53,735,450 | 4,086,346 | SH | SOLE | 4,086,346 | 0 | 0 |